Helius Medical Technologies Inc Class AHSDT
Mentioned
Impact on stocks 1
Brain-Computer Interface
Helius Medical Technologies Inc Class ASolana Company expects first validator rewards in Q3 2026
EarningsCorporate Action
Solana Company expects to recognize its first validator-related rewards in the third quarter of 2026 after securing a third-party stake commitment of around 0.5 million SOL in July. CEO Choon Wee Chee said the company's first institutional validated cluster is operational in Tokyo and that staking rewards contributed $2.5 million, or 31,200 SOL, in the second quarter. The company reported second quarter revenue of $2.5 million, a net loss of $30.3 million, and executed approximately $2.3 million of share repurchases while holding about 2.3 million SOL as of June 30, 2026. Management also divested the cash-consuming medical device business and acquired a Hong Kong regulated trust company.